We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Accurately Identifies Breast Cancer Using Low-Cost Portable Ultrasound Machines

By MedImaging International staff writers
Posted on 04 May 2023
Print article
Image: AI can be helpful in triaging breast masses in low-resource areas (Photo courtesy of Freepik)
Image: AI can be helpful in triaging breast masses in low-resource areas (Photo courtesy of Freepik)

Breast lumps are often discovered unintentionally during breast self-exams or medical professional examinations. Breast cancer screening can detect cancers before a lump becomes palpable. While cancer screening is emphasized in Western countries, low- and middle-income countries frequently lack access to organized screening programs and technology. In these countries, breast cancer is typically identified as a palpable lump. Ultrasound can significantly contribute to early detection, leading to more effective, less invasive treatments and improved outcomes. A new study has discovered that artificial intelligence (AI) can analyze breast mass images from low-cost portable ultrasound machines and accurately identify cancer, which could be beneficial for triage in resource-limited settings.

In a multicenter study, researchers at the University of Pittsburgh School of Medicine (Pittsburgh, PA, USA) enrolled participants with at least one palpable breast lump. Portable ultrasound machines were used to obtain images of the lump site and adjacent tissue, followed by standard-of-care ultrasound imaging. A radiologist performed Breast Imaging-Reporting and Data System (BI-RADS) assessments. After exclusions, the AI software analyzed 758 masses in 300 women (average age 50.0 years) as benign, probably benign, suspicious, or malignant (cancerous). The average age of the participants ranged from 18 to 92 years, and the mean largest lesion diameter was 13 mm (range 2-54). Out of 758 masses, 360 (47.5%) were palpable, and 56 (7.4%) were malignant.

AI accurately identified 96% and 98% of women with cancer using low-cost portable ultrasound and standard-of-care ultrasound images, respectively. For benign masses, 67% could have been appropriately triaged with standard-of-care ultrasound, and 38% with portable ultrasound. Although specificity was lower than with standard-of-care equipment, AI applied to portable breast ultrasound has the potential to reduce specialized hospital referrals by approximately half in resource-limited areas. It is important to note that the researchers did not train AI on images from the portable ultrasound. Moreover, low-cost portable ultrasound technology has advanced since the study was conducted. The researchers anticipate even better results in the future with improved images and AI training.

“Our results show great promise for the use of AI and portable ultrasound in low-resource settings, including remote/underserved areas in the United States, to help improve breast health care,” said the study’s lead author Wendie A. Berg, M.D., Ph.D., professor of radiology at the University of Pittsburgh School of Medicine. “In reducing the number of women with benign lumps who need to be seen in central facilities and potentially have a biopsy, health care resources can be better focused on women with cancer and reduce delays in diagnosis. This should improve access, health equity and outcomes for women.”

Related Links:
University of Pittsburgh School of Medicine

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Breast Imaging Workstation
SecurView
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.